Civic Intelligence

Vanguard Urologic Research Foundation

990 • Fiscal year 2012 • EIN 20-5972989

Jan 01, 2012 to Dec 31, 2012

Surfside, FL
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

97th percentile

1.95x

Higher debt load relative to assets than 97% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Liabilities / Revenue

91st percentile

0.42x

Higher debt load relative to revenue than 91% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Net Margin

11th percentile

-34%

Higher net margin than 11% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

83rd percentile

43%

Faster asset growth than 83% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Annualized from 2011 to 2012

Revenue Growth

9th percentile

-50%

Faster revenue growth than 9% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Annualized from 2011 to 2012

Assets

Up

$92,725

Up $27,776 (+43%) from 2011

Net Assets

Down

-$87,930

Down $144,387 (-256%) from 2011

Liabilities

Up

$180,655

Up $172,163 (+2027%) from 2011

Revenue

Down

$427,570

Down $433,166 (-50%) from 2011

Expenses

Down

$571,957

Down $331,914 (-37%) from 2011

Net Income

Down

-$144,387

Down $101,252 (-235%) from 2011

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200K$100K$0-$100KAssets 2010: $114,871Liabilities 2010: $15,279Net Assets 2010: $99,5922010Assets 2011: $64,949Liabilities 2011: $8,492Net Assets 2011: $56,4572011Assets 2012: $92,725Liabilities 2012: $180,655Net Assets 2012: -$87,9302012Assets 2013: $4,484Liabilities 2013: $0Net Assets 2013: $4,4842013Assets 2014: $13,196Liabilities 2014: $333Net Assets 2014: $12,8632014Assets 2015: $1,409Liabilities 2015: $7,434Net Assets 2015: -$6,0252015Assets 2016: $2,265Liabilities 2016: $267Net Assets 2016: $1,9982016Assets 2017: $28,490Liabilities 2017: $899Net Assets 2017: $27,5912017Assets 2018: $0Liabilities 2018: $0Net Assets 2018: $02018

Highlighted filing

2012

Assets$92,725
Liabilities$180,655
Net Assets-$87,930

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2010: $671,720Expenses 2010: $651,375Net Income 2010: $20,3452010Revenue 2011: $860,736Expenses 2011: $903,871Net Income 2011: -$43,1352011Revenue 2012: $427,570Expenses 2012: $571,957Net Income 2012: -$144,3872012Revenue 2013: $285,533Expenses 2013: $193,120Net Income 2013: $92,4132013Revenue 2014: $74,093Expenses 2014: $65,714Net Income 2014: $8,3792014Revenue 2015: $24,013Expenses 2015: $42,901Net Income 2015: -$18,8882015Revenue 2016: $22,006Expenses 2016: $13,984Net Income 2016: $8,0222016Revenue 2017: $35,015Expenses 2017: $9,421Net Income 2017: $25,5942017Revenue 2018: $20Expenses 2018: $27,611Net Income 2018: -$27,5912018

Highlighted filing

2012

Revenue$427,570
Expenses$571,957
Net Income-$144,387
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

To establish the premier translation research program focused on prostate disease including prostate cancer and related diseases of the aging process.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings